Enclave Advisors LLC
- SEC CIK
- 0001836110
- Latest filing
- Jul 14, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Enclave Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 602
- Value
- $722.6K
- % of portfolio
- 0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 602 | $722.6K | 0.1% | +67+12.5% | Added | Holders |
| Q1 2026 | 535 | $492.5K | 0.1% | −31−5.5% | Reduced | Holders |
| Q4 2025 | 566 | $608.7K | 0.1% | +5+0.9% | Added | Holders |
| Q3 2025 | 561 | $428.2K | 0.1% | +85+17.9% | Added | Holders |
| Q2 2025 | 476 | $371.0K | 0.1% | +51+12.0% | Added | Holders |
| Q1 2025 | 425 | $350.7K | 0.1% | +15+3.7% | Added | Holders |
| Q4 2024 | 410 | $316.8K | 0.1% | +30+7.9% | Added | Holders |
| Q3 2024 | 380 | $336.7K | 0.1% | – | No prior filing | Holders |